|Articles|June 5, 2023
- Pharmaceutical Executive: June 2023
- Volume 43
- Issue 6
Pharmaceutical Executive, June 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive June 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
2023 Pharm Exec Top 50 Companiesover 2 years ago
Great Leaders Listenover 2 years ago
Measuring Pharma’s Trust Performanceover 2 years ago
Tapping NPs and PAs in Life Sciences Marketingover 2 years ago
The Quest to Fully Address Prescription Drug Affordabilityover 2 years ago
How Pharma Should Prepare for Looming Nursing Shortageover 2 years ago
Could a Rates Pivot By Fed Change Biotech’s Fate?over 2 years ago
New EU Proposals to Regulate Pharma Duck the Difficult QuestionsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
